Before You Share Your Deal: 7 GP Capital Questions

Capital qualification is execution risk management

Capital raising is not a marketing exercise. It is an underwriting process—on both sides of the table.

General Partners (GPs) often assume that once a deal is “ready,” the next logical step is broad distribution: send the deck, schedule calls, collect soft circles, and move toward closing. But institutional capital does not behave like retail capital. It does not deploy based on enthusiasm. It deploys based on mandate, structure, governance, and internal constraints.

In today’s environment, where underwriting standards have tightened and fundraising cycles have lengthened, deployable capital aligned to your strategy is frequently more constrained than headline “dry powder” suggests. Fundraising can take materially longer than many GPs expect, and the time cost of chasing misaligned counterparties has become a major performance drag.[1][2]

The most experienced GPs understand a simple distinction:

• Interest is not capital.
• Capital is not liquidity.
• Liquidity is not discretion.

This article is designed as a practical screening tool: seven questions every GP should ask a capital partner before sharing a deal. These aren’t “nice-to-have” questions. They are execution filters that prevent late-stage surprises, protect confidentiality, and preserve momentum.

Before you share your deal: 7 questions every GP should ask a capital partner

1) Do you control discretionary capital?

This is the first and most important filter.

There is a fundamental structural difference between a counterparty that controls capital and one that influences capital. Many market participants can express enthusiasm, broker introductions, or assemble “interest.” Far fewer can write a check under their own authority.

If the counterparty does not control discretionary capital, your deal enters a referral chain. Every additional layer introduces time delay, mandate mismatch risk, confidentiality dilution, and re-trade risk.

2) Is the capital committed to a vehicle?

Many GPs confuse interested capital with allocated capital.

Institutional investors typically deploy through defined structures such as closed-end funds, evergreen vehicles, separate accounts, structured mandates, or co-investment programs. If capital is not already committed to an investable vehicle, deployment certainty declines.[3][4]

3) What was your last executed transaction?

Nothing reveals real capability like recent behavior. A capital partner’s last executed transaction gives insight into deployment velocity, realistic check size, and operational readiness.[1][2]

4) What is your internal investment committee (IC) process?

The IC process determines timeline risk. Even discretionary capital must pass governance, and approval structures vary significantly across institutions.[5][6]

5) What ticket size is realistic?

Institutional ticket sizes are constrained by portfolio construction rules and concentration limits. Understanding median and maximum exposure levels prevents structural mismatch.

6) What return profile is mandated?

Capital is governed by mandates, not preferences. Target IRR, hold period, and downside protection requirements are structural constraints—not negotiable preferences.

7) Are you regulated or operating under advisory scope?

Regulatory status affects compliance timelines, reporting requirements, and commitment authority. RIAs and other regulated entities operate under fiduciary and disclosure frameworks that shape execution speed.[7][8][9]

Capital is not capital: structural differences that determine execution

Capital differs across governance complexity, liquidity source, time horizon, risk tolerance, and regulatory overlay. Execution probability is determined less by enthusiasm and more by structural alignment.

Conclusion

Before you share your deal, confirm discretion, mandate fit, vehicle structure, IC process, ticket size, return profile, and regulatory scope. Capital is not capital. Structure determines execution.

Key takeaways

• Discretion matters more than interest.
• Committed vehicles deploy faster than advisory structures.
• IC structure determines timeline feasibility.
• Realistic ticket sizes prevent structural mismatch.
• Mandated return profiles are constraints, not preferences.
• Regulatory scope impacts closing certainty.

References

1. [1] PitchBook: PE funds are taking longer to close
2. [2] Preqin: State of Private Capital Fundraising in 2025
3. [3] Investopedia: Structure of a Private Equity Fund
4. [4] Investopedia: Liquidity and lockups in private markets
5. [5] Investopedia: Investment committees
6. [6] Investopedia: Understanding Private Equity
7. [7] Investopedia: Registered Investment Advisor (RIA)
8. [8] SEC: Regulation of Investment Advisers
9. [9] Comply: SEC view on RIA fiduciary duty